| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of the combination of high-dose epirubicin with gemcitabine in advanced non-small-cell lung cancer
|
Van Putten, John W.G
|
|
2001
|
34 |
S4 |
p. 61-64
4 p.
|
artikel
|
| 2 |
ALIMTA® (pemetrexed disodium, LY231514, MTA): clinical experience in non-small cell lung cancer
|
Novello, S
|
|
2001
|
34 |
S4 |
p. 107-109
3 p.
|
artikel
|
| 3 |
Angiogenesis and antiangiogenic agents in non-small cell lung cancer
|
Galligioni, Enzo
|
|
2001
|
34 |
S4 |
p. 3-7
5 p.
|
artikel
|
| 4 |
Anthacyclines in non-small cell lung cancer
|
Pronzato, Paolo
|
|
2001
|
34 |
S4 |
p. 57-59
3 p.
|
artikel
|
| 5 |
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis
|
Santo, Antonio
|
|
2001
|
34 |
S4 |
p. 15-20
6 p.
|
artikel
|
| 6 |
Author index
|
|
|
2001
|
34 |
S4 |
p. 117-118
2 p.
|
artikel
|
| 7 |
Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer
|
Kakolyris, S
|
|
2001
|
34 |
S4 |
p. 71-76
6 p.
|
artikel
|
| 8 |
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial
|
Georgoulias, V.
|
|
2001
|
34 |
S4 |
p. 47-51
5 p.
|
artikel
|
| 9 |
Contents
|
|
|
2001
|
34 |
S4 |
p. v-vi
nvt p.
|
artikel
|
| 10 |
Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study
|
Mattson, K
|
|
2001
|
34 |
S4 |
p. 21-23
3 p.
|
artikel
|
| 11 |
Gemcitabine and pemetrexed disodium combinations in vitro and in vivo
|
Adjei, Alex A
|
|
2001
|
34 |
S4 |
p. 103-105
3 p.
|
artikel
|
| 12 |
Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial
|
Frasci, Giuseppe
|
|
2001
|
34 |
S4 |
p. 65-69
5 p.
|
artikel
|
| 13 |
Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer
|
Rinaldi, Massimo
|
|
2001
|
34 |
S4 |
p. 25-30
6 p.
|
artikel
|
| 14 |
Is there a standard strategy in the management of locally advanced non-small cell lung cancer?
|
Novello, S
|
|
2001
|
34 |
S4 |
p. 9-14
6 p.
|
artikel
|
| 15 |
Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer
|
Greco, F.Anthony
|
|
2001
|
34 |
S4 |
p. 53-56
4 p.
|
artikel
|
| 16 |
Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer
|
Momparler, Richard L
|
|
2001
|
34 |
S4 |
p. 111-115
5 p.
|
artikel
|
| 17 |
Preface
|
Cartei, Giuseppe
|
|
2001
|
34 |
S4 |
p. 1-
1 p.
|
artikel
|
| 18 |
Radiosensitization with chemotherapeutic agents
|
Caffo, Orazio
|
|
2001
|
34 |
S4 |
p. 81-90
10 p.
|
artikel
|
| 19 |
Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results
|
Klastersky, J.
|
|
2001
|
34 |
S4 |
p. 95-101
7 p.
|
artikel
|
| 20 |
Role of erythropoietin in the treatment of lung cancer associated anaemia
|
Scagliotti, G.V
|
|
2001
|
34 |
S4 |
p. 91-94
4 p.
|
artikel
|
| 21 |
Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study
|
Agelaki, Sophia
|
|
2001
|
34 |
S4 |
p. 77-80
4 p.
|
artikel
|
| 22 |
Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer
|
Tumolo, S
|
|
2001
|
34 |
S4 |
p. 37-46
10 p.
|
artikel
|
| 23 |
Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study
|
Valerio, Maria Rosaria
|
|
2001
|
34 |
S4 |
p. 31-35
5 p.
|
artikel
|
Tijdschrift beschrijving